Velico: Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma

BARDA has extended its Spray Dried Plasma development contract with Velico Medical through November 2019 providing for an additional $18.9 million. This nondilutive funding is expected to support the companys development program through FDA approval to co...